within Pharmacolibrary.Drugs.C_CardiovascularSystem.C09B_AceInhibitorsCombinations.C09BB02_EnalaprilAndLercanidipine;
model EnalaprilAndLercanidipine 
   extends Pharmacolibrary.Drugs.ATC.C.C09BB02;

  annotation(Documentation(
    info ="<html><body><p>Fixed-dose combination of enalapril, an angiotensin-converting enzyme (ACE) inhibitor, and lercanidipine, a dihydropyridine calcium channel blocker. Used for the treatment of essential hypertension in adults. The combination is approved and used clinically in several countries for better blood pressure control.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for fixed-dose oral administration in adults, as no specific pharmacokinetic model for the combination are reported in published literature.</p><h4>References</h4><ol><li><p>McClellan, KJ, &amp; Jarvis, B (2000). Lercanidipine: a review of its use in hypertension. <i>Drugs</i> 60(5) 1123â€“1140. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200060050-00009&quot;>10.2165/00003495-200060050-00009</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11129125/&quot;>https://pubmed.ncbi.nlm.nih.gov/11129125</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end EnalaprilAndLercanidipine;
